In 2025, abinScience launches its Recombinant Protein Portfolio with 10,000+ SKUs covering cytokines, CD antigens, receptors, and complement proteins. Featuring high batch consistency, animal-free production, <1 EU/μg endotoxin, and carrier-free formulation, we support 200+ global labs in functional assays, ELISA, flow cytometry, and CAR-T research.
Powered by HEK293, CHO, insect cell, and E. coli platforms, abinScience delivers purity >95% with MS-validated COA — from IL series to PD-1/PD-L1, from Taq polymerase to SUMO protease — one-stop solution for your research needs.
Fig.1. abinScience Recombinant Protein Portfolio Overview (2025)
Quality Commitment: Each lot includes COA, endotoxin report, and QC validation. High batch-to-batch consistency with low typical CV values.
For research use only. Not for clinical or therapeutic use.
Core Advantages & Expression Platforms
abinScience proteins follow the “5 Highs & 1 Low” standard:
High SKU Count: 10,000+ proteins across human, mouse, monkey, pig
High Purity: >95%, single band on SDS-PAGE
High Bioactivity: Validated via cell proliferation & receptor binding
High Consistency: Low batch-to-batch CV
High Safety: Animal-free, BSA-free
Low Endotoxin: <1 EU/μg (LAL method)
Fig.2. abinScience Full QC Workflow (HEK293/CHO/Insect/E. coli Platforms)
HEK293
CHO
Insect
E. coli
Four Expression Platforms (Industry Standard)
Platform
Advantages & Applications
Featured Products
HEK293 (Transient)
Human-like glycosylation, correct folding, fast expression (7–10 days)
Suitable for difficult proteins, membrane proteins, GPCRs, human glycosylation needed Note: Higher cost for long-term scale-up
Ideal for large/multi-disulfide proteins, VLPs Glycosylation: paucimannose + α1,3-Fuc, differs from human Research-grade antigens; switch to HEK/CHO for clinical function
Platform Selection Guide:
• Human glycosylation + fast validation → HEK293
• Therapeutic/large-scale → CHO stable line
• Viral antigens/VLPs → Insect (research-grade)
• Enzymes/non-glycosylated → E. coli
All platforms include COA + endotoxin + SDS-PAGE + activity report
Key Application Areas
abinScience proteins cover 8 core research fields, from basic research to clinical translation:
Founded in 2023 in France, abinScience specializes in high-end recombinant proteins and antibodies. Serving 200+ top global labs in immunology, oncology, virology, and tool enzymes.
Top 20 Bestsellers (2025)
Our 2025 Top 20 recombinant proteins — viral antigens, cytokines, checkpoints, animal models. 24h shipping, scan for support!
中文
English
